Toru Kitazawa

Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study.

M. Fujiwara, Hideyoshi Kaga, Y. Kojima, 2013, World journal of diabetes.

Combination therapy of glucagon‐like peptide‐1 receptor agonists and insulin for patients who developed diabetes after partial pancreatectomy

K. Yokoyama, Toru Kitazawa, Ken Kubota, 2015, Journal of diabetes investigation.

Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial (STOP‐OB)

M. Anai, M. Fujishiro, H. Ishihara, 2020, Diabetes, obesity & metabolism.

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

N. Kumashiro, T. Hirose, T. Ichijo, 2020, Cardiovascular diabetology.

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy

M. Anai, M. Fujishiro, H. Ishihara, 2018, Diabetes Therapy.

Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study)

H. Seino, H. Akai, N. Kamei, 2023, Diabetes Therapy.

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

R. Iijima, T. Shiba, T. Kohro, 2013, Lipids in Health and Disease.

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

R. Iijima, T. Shiba, T. Kohro, 2013, Lipids in Health and Disease.